Clinical Trial Update: An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating cisapride for chronic gastroparesis after failure of other treatments was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• Cisapride (cisapride)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Gastroparesis | Phase 4 | Status: TERMINATED